1,372
Views
11
CrossRef citations to date
0
Altmetric
Report

cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response

, , , , &
Pages 1267-1275 | Received 14 Dec 2015, Accepted 26 Feb 2016, Published online: 17 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gulnur K Zakiryanova, Sarah Wheeler & Michael R Shurin. (2018) Oncogenes in immune cells as potential therapeutic targets. ImmunoTargets and Therapy 7, pages 21-28.
Read now

Articles from other publishers (10)

Mehdi Allahbakhshian Farsani, Mohammad Rafiee, Hamideh Aghaee Nezhad, Sina Salari, Arshia Gharehbaghian & Mohammad Hossein Mohammadi. (2019) The Expression of P53, MDM2, c-myc, and P14ARF Genes in Newly Diagnosed Acute Lymphoblastic Leukemia Patients. Indian Journal of Hematology and Blood Transfusion 36:2, pages 277-283.
Crossref
Yiyu Chen, Zhen Liu, Huijun Wang, Zibo Tang, Yiyi Liu, Zixi Liang, Xiaojie Deng, Mengyang Zhao, Qiaofen Fu, Libo Li, Hongbing Cai, Weibing Xie & Weiyi Fang. (2019) VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer. International Journal of Cancer 146:2, pages 496-509.
Crossref
Dan Xu, Bao Wang, Pan-pan Chen, Yan-zhe Wang, Nai-jun Miao, Fan Yin, Qian Cheng, Zhuan-li Zhou, Hong-yan Xie, Li Zhou, Jun Liu, Xiao-xia Wang, Hong Xue, Wei Zhang & Li-min Lu. (2018) c-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway. Acta Pharmacologica Sinica 40:8, pages 1058-1066.
Crossref
Gema Sanz, Madhurendra Singh, Sylvain Peuget & Galina Selivanova. (2019) Inhibition of p53 inhibitors: progress, challenges and perspectives. Journal of Molecular Cell Biology 11:7, pages 586-599.
Crossref
A. I. Glukhov, G. K. Gryzunova, L. I. Usai, T L. Aleynikova, N. V. Chernikova & A. Yu. Burt. (2019) The Role of Apoptosis in the Pathogenic Mechanism of Critical States (Review). General Reanimatology 15:2, pages 79-98.
Crossref
Zixi Liang, Zhen Liu, Chao Cheng, Hao Wang, Xiaojie Deng, Jiahao Liu, Chen Liu, Yonghao Li & Weiyi Fang. (2019) VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma. Cell Death & Disease 10:4.
Crossref
Alessandra Tuccitto, Eriomina Shahaj, Elisabetta Vergani, Simona Ferro, Veronica Huber, Monica Rodolfo, Chiara Castelli, Licia Rivoltini & Viviana Vallacchi. (2018) Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy. Virchows Archiv 474:4, pages 407-420.
Crossref
Liren Jiang, Natasha Malik, Pilar Acedo & Joanna Zawacka-Pankau. (2019) Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells. Cell Death Discovery 5:1.
Crossref
A. S. Diatlova, A. V. Dudkov, N. S. Linkova & V. Kh. Khavinson. (2018) Molecular Markers of Caspase-Dependent and Mitochondrial Apoptosis: Role in the Development of Pathology and Cellular Senescence. Biology Bulletin Reviews 8:6, pages 472-481.
Crossref
Jun Chen, Jian-Hao Li, Shan-Jun Zhao, Da-Yu Wang, Wen-Zhu Zhang & Wei-Jie Liang. (2017) Clinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease. Medicine 96:32, pages e7634.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.